Consolidated Statement of Changes in Equity - CAD ($) $ in Millions |
Total |
Schwab [member] |
Contributed Surplus [Member] |
Retained earnings [member] |
Accumulated other comprehensive income [member] |
Accumulated other comprehensive income [member]
Reserve of cash flow hedges [member]
|
Accumulated other comprehensive income [member]
Reserve of change in fair value of financial liability attributable to change in credit risk of liability [member]
|
Accumulated other comprehensive income [member]
Reserve of exchange differences on translation [member]
|
Accumulated other comprehensive income [member]
Financial Assets At Fair Value Through Other Comprehensive Income [Member]
|
Accumulated other comprehensive income [member]
Equity Securities At Fair Value Through Other Comprehensive Income [Member]
|
Accumulated other comprehensive income [member]
Schwab [member]
|
Equity attributable to owners of parent [member] |
Common shares [member]
Retained earnings [member]
|
Common shares [member]
Issued capital [member]
|
Common shares [member]
Treasury shares [member]
|
Preferred shares and other equity instruments [member] |
Preferred shares and other equity instruments [member]
Retained earnings [member]
|
Preferred shares and other equity instruments [member]
Issued capital [member]
|
Preferred shares and other equity instruments [member]
Treasury shares [member]
|
Balance at beginning of period (Impact on adoption [member]) at Oct. 31, 2022 |
|
|
|
$ 112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of period at Oct. 31, 2022 |
|
|
$ 179
|
73,698
|
|
$ (5,717)
|
$ 78
|
$ 12,048
|
$ (476)
|
$ 23
|
|
|
|
$ 24,363
|
$ (91)
|
|
|
$ 11,253
|
$ (7)
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of stock options, net of options exercised |
|
|
15
|
|
|
|
|
|
|
|
|
|
|
71
|
|
|
|
|
|
Shares issued as a result of dividend reinvestment plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,418
|
|
|
|
|
|
Purchase of shares for cancellation and other |
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
Purchase of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,051)
|
|
|
|
(326)
|
Purchase of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
(326)
|
Sale of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
323
|
Sale of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,043
|
|
|
|
|
Net premium (discount) on sale of treasury instruments |
|
|
(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
(25)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to equity instrument holders |
|
|
|
4,887
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred dividends and distributions on other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
$ (3,500)
|
|
|
|
$ (293)
|
|
|
Net premium on repurchase of common shares and redemption of preferred shares and other equity instruments |
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remeasurement gain/(loss) on employee benefit plans |
$ 17
|
|
|
17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Realized gain/(loss) on equity securities designated at fair value through other comprehensive income |
|
|
|
(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
285
|
|
|
|
|
|
|
|
286
|
|
|
|
|
|
|
|
|
|
|
Allowance for credit losses | IFRS 17 [member] |
|
|
|
0
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for credit losses |
(1)
|
|
|
|
|
|
|
|
(1)
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
(133)
|
|
|
|
|
|
|
|
|
|
Reclassification of loss/(gain) to retained earnings |
|
|
|
|
|
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
(94)
|
|
|
|
|
|
(94)
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
(744)
|
|
|
|
|
|
|
(744)
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
2,100
|
|
|
|
|
2,100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of accumulated other comprehensive income (loss) from investment in Schwab |
|
$ 700
|
|
|
|
|
|
|
|
|
$ (3,268)
|
|
|
|
|
|
|
|
|
Balance at end of period at Apr. 30, 2023 |
|
|
161
|
74,915
|
4,108
|
(3,617)
|
(16)
|
11,304
|
(191)
|
(104)
|
|
$ 116,180
|
|
25,852
|
(99)
|
$ 11,253
|
|
11,253
|
(10)
|
Balance at beginning of period (Impact on adoption [member]) at Jan. 31, 2023 |
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of period at Jan. 31, 2023 |
|
|
185
|
73,612
|
|
(3,992)
|
(99)
|
10,008
|
(305)
|
32
|
|
|
|
25,094
|
(103)
|
|
|
11,253
|
(9)
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of stock options, net of options exercised |
|
|
5
|
|
|
|
|
|
|
|
|
|
|
45
|
|
|
|
|
|
Shares issued as a result of dividend reinvestment plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
713
|
|
|
|
|
|
Purchase of shares for cancellation and other |
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
Purchase of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,235)
|
|
|
|
(185)
|
Purchase of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
(185)
|
Sale of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
184
|
Sale of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,239
|
|
|
|
|
Net premium (discount) on sale of treasury instruments |
|
|
(11)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
(18)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to equity instrument holders |
|
|
|
3,306
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred dividends and distributions on other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
(1,754)
|
|
|
|
(210)
|
|
|
Net premium on repurchase of common shares and redemption of preferred shares and other equity instruments |
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remeasurement gain/(loss) on employee benefit plans |
(35)
|
|
|
(35)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Realized gain/(loss) on equity securities designated at fair value through other comprehensive income |
|
|
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
114
|
|
|
|
|
|
|
|
114
|
|
|
|
|
|
|
|
|
|
|
Allowance for credit losses | IFRS 17 [member] |
|
|
|
0
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for credit losses |
0
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
(140)
|
|
|
|
|
|
|
|
|
|
Reclassification of loss/(gain) to retained earnings |
|
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
83
|
|
|
|
|
|
83
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
1,296
|
|
|
|
|
|
|
1,296
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
375
|
|
|
|
|
375
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of accumulated other comprehensive income (loss) from investment in Schwab |
|
453
|
|
|
|
|
|
|
|
|
(3,268)
|
|
|
|
|
|
|
|
|
Balance at end of period at Apr. 30, 2023 |
|
|
161
|
74,915
|
4,108
|
(3,617)
|
(16)
|
11,304
|
(191)
|
(104)
|
|
116,180
|
|
25,852
|
(99)
|
11,253
|
|
11,253
|
(10)
|
Balance at beginning of period (Impact on adoption [member]) at Oct. 31, 2023 |
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of period at Oct. 31, 2023 |
112,071
|
|
155
|
73,008
|
|
(5,472)
|
(38)
|
12,677
|
(413)
|
(127)
|
|
|
|
25,434
|
(64)
|
|
|
10,853
|
(65)
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of stock options, net of options exercised |
|
|
13
|
|
|
|
|
|
|
|
|
|
|
66
|
|
|
|
|
|
Shares issued as a result of dividend reinvestment plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
269
|
|
|
|
|
|
Purchase of shares for cancellation and other |
|
|
|
|
|
|
|
|
|
|
|
|
|
(512)
|
|
|
|
|
|
Purchase of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,250)
|
|
|
|
(251)
|
Purchase of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
350
|
(251)
|
Sale of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
308
|
Sale of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,290
|
|
|
|
|
Net premium (discount) on sale of treasury instruments |
|
|
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to equity instrument holders |
|
|
|
5,388
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred dividends and distributions on other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
(3,602)
|
|
|
|
(264)
|
|
|
Net premium on repurchase of common shares and redemption of preferred shares and other equity instruments |
|
|
|
(2,430)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remeasurement gain/(loss) on employee benefit plans |
(186)
|
|
|
(186)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Realized gain/(loss) on equity securities designated at fair value through other comprehensive income |
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
219
|
|
|
|
|
|
|
|
210
|
|
|
|
|
|
|
|
|
|
|
Allowance for credit losses | IFRS 17 [member] |
|
|
|
10
|
(10)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for credit losses |
(1)
|
|
|
|
|
|
|
|
(1)
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
180
|
|
|
|
|
|
|
|
|
|
Reclassification of loss/(gain) to retained earnings |
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
0
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
(491)
|
|
|
|
|
|
|
(491)
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
682
|
|
|
|
|
682
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of accumulated other comprehensive income (loss) from investment in Schwab |
|
826
|
|
|
|
|
|
|
|
|
(3,051)
|
|
|
|
|
|
|
|
|
Balance at end of period at Apr. 30, 2024 |
111,982
|
|
184
|
71,904
|
4,166
|
(4,790)
|
(38)
|
12,186
|
(194)
|
53
|
|
111,982
|
|
25,257
|
(24)
|
10,503
|
|
10,503
|
(8)
|
Balance at beginning of period (Impact on adoption [member]) at Jan. 31, 2024 |
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of period at Jan. 31, 2024 |
|
|
172
|
72,347
|
|
(3,504)
|
(77)
|
10,550
|
(163)
|
19
|
|
|
|
25,318
|
(58)
|
|
|
10,853
|
(27)
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of stock options, net of options exercised |
|
|
8
|
|
|
|
|
|
|
|
|
|
|
24
|
|
|
|
|
|
Shares issued as a result of dividend reinvestment plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
132
|
|
|
|
|
|
Purchase of shares for cancellation and other |
|
|
|
|
|
|
|
|
|
|
|
|
|
(217)
|
|
|
|
|
|
Purchase of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,154)
|
|
|
|
(153)
|
Purchase of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
350
|
(153)
|
Sale of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
172
|
Sale of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,188
|
|
|
|
|
Net premium (discount) on sale of treasury instruments |
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to equity instrument holders |
|
|
|
2,564
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred dividends and distributions on other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
$ (1,795)
|
|
|
|
$ (190)
|
|
|
Net premium on repurchase of common shares and redemption of preferred shares and other equity instruments |
|
|
|
(1,002)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remeasurement gain/(loss) on employee benefit plans |
(22)
|
|
|
(22)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Realized gain/(loss) on equity securities designated at fair value through other comprehensive income |
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
(31)
|
|
|
|
|
|
|
|
(31)
|
|
|
|
|
|
|
|
|
|
|
Allowance for credit losses | IFRS 17 [member] |
|
|
|
0
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for credit losses |
0
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
36
|
|
|
|
|
|
|
|
|
|
Reclassification of loss/(gain) to retained earnings |
|
|
|
|
|
|
|
|
|
(2)
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
39
|
|
|
|
|
|
39
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
1,636
|
|
|
|
|
|
|
1,636
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
(1,286)
|
|
|
|
|
(1,286)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of accumulated other comprehensive income (loss) from investment in Schwab |
|
$ (56)
|
|
|
|
|
|
|
|
|
$ (3,051)
|
|
|
|
|
|
|
|
|
Balance at end of period at Apr. 30, 2024 |
$ 111,982
|
|
$ 184
|
$ 71,904
|
$ 4,166
|
$ (4,790)
|
$ (38)
|
$ 12,186
|
$ (194)
|
$ 53
|
|
$ 111,982
|
|
$ 25,257
|
$ (24)
|
$ 10,503
|
|
$ 10,503
|
$ (8)
|